PSMA positron emission tomography-computed tomography (PSMAPET-CT) was found to be 27% more accurate compared to conventional CT and bone scans. This was discovered in a phase 3 study conducted to detect distant metastases in high-risk prostate cancer patients. According to research, PSMA PET-CT can help stage men with high risk localized prostate cancer more accurately
